Market access

Innovative access and pricing solutions

Our specialist market access team supports the world’s leading pharmaceutical, biotech and device manufacturers in market access, pricing and reimbursement. We provide our clients with the insights and recommendations they need to develop the value strategy for their technologies and optimise their revenues

Our portfolio of services include:

Portfolio planning & optimisation

Portfolio planning & optimisation

A successful portfolio strategy sets direction for the future and maximises value. We will help you to plan the strategic management of your product portfolio, enabling you to make the right investment decisions, optimise value, and allocate the most profitable use of resources.

View a case study

Pricing and reimbursement

Pricing and reimbursement

Strategic pricing is essential to maximising revenue and achieving long-term organisational results. Our market insights will help to develop pricing and reimbursement strategies that reflect, maintain, and enhance the value of your assets over their lifetime.

View a case study

Landscape assessment

Landscape assessment

A comprehensive landscape assessment is vital for identifying the access opportunities and challenges for your product. We will assess the current and future treatment, pricing, and reimbursement landscape to ensure that your market access strategies are underpinned by high-value insights.

View a case study

Product profile evaluation

Product profile evaluation

We test and develop target product profiles with experts payers and KOLs to assess their market access potential. We use their feedback on the perceived value of your product to identify evidence gaps, provide guidance on minimum thresholds to achieve reimbursement and input into future development plans. 

View a case study

Payer engagement

Payer engagement

Innovative engagement approaches are invaluable for improving payer relationships. We will develop a range of payer engagement programmes including expert panels, advisory boards, mock negotiations and training sessions to ensure closer proximity with payers and establish long-term trust-based relationships.

View a case study

Emerging market expertise

Emerging market expertise

We conduct payer research in over 50 mature and emerging markets including Brazil, India and China to help you maximise your competitive advantage in the markets offering the best opportunities for growth.


View a case study

Market access resources:

Keeping up with coronavirus Sept 2020

Webinar

Keeping up with the Coronavirus: Monitoring the impact of COVID-19 on the market access landscape.

View

US Flags_rapport

Article

How will COVID-19 affect the financing of healthcare provision across the US?

Find out more

Rectangle 51@2x

Infographic

Selected deals for SARS-CoV-2 vaccines in late stage development.


Download

Request more information

Brett Gardiner - Staff Profile

Brett Gardiner

Director, Market Access

Brett is a Director and heads up our specialist market access team. Brett has managed and contributed to the development of pricing and reimbursement strategies for pharmaceuticals and medical devices in all stages of the product life-cycle across all major European markets, US, Japan, Canada as well as many emerging markets. Brett has particular experience in asset valuation and value communication as well as more complex pricing research: moderation of payer and KOL dyads, focus groups, advisory boards, mock formulary committees and P&R negotiation simulations.